Haleon (HLN) Current Taxes (2021 - 2025)
Haleon (HLN) posted Current Taxes of $355.2 million for Q4 2025, up 17.75% on a QoQ basis from $301.6 million in Q4 2024, and up 17.75% year-over-year from $301.6 million in Q4 2024.
Haleon (HLN) Current Taxes (2021 - 2025) Analysis & Trends
Haleon's Current Taxes history runs 5 years deep, the most recent figure standing at $355.2 million for Q4 2025.
- Quarterly Current Taxes rose 17.75% year-over-year to $355.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $355.2 million (up 17.75% YoY) and the FY2025 annual result came in at $352.0 million, up 17.19% from the prior year.
- Current Taxes was $355.2 million for Q4 2025 at Haleon, up from $301.6 million in the prior quarter.
- Across five years, Current Taxes topped out at $357.5 million in Q4 2023 and bottomed at -$388.8 million in Q2 2024.
- A 5-year average of $59.4 million and a median of $259.3 million in 2021 frame the typical range for Current Taxes.
- Peak annual rise in Current Taxes reached 45.12% in 2023, while the deepest fall reached 25.05% in 2023.
- Haleon's Current Taxes stood at $272.3 million in 2021, then slipped by 9.54% to $246.3 million in 2022, then soared by 45.12% to $357.5 million in 2023, then dropped by 15.62% to $301.6 million in 2024, then grew by 17.75% to $355.2 million in 2025.
- Business Quant data shows HLN's Current Taxes at $355.2 million in Q4 2025, $301.6 million in Q4 2024, and -$388.8 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 355.15 Mn |
| Dec 31, 2024 | 301.62 Mn |
| Jun 30, 2024 | -388.76 Mn |
| Dec 31, 2023 | 357.45 Mn |
| Jun 30, 2023 | -371.65 Mn |
| Dec 31, 2022 | 246.31 Mn |
| Jun 30, 2022 | -297.20 Mn |
| Dec 31, 2021 | 272.30 Mn |